Advestra advised Citigroup, UBS and Stifel Europe in connection with ther joint global coordination role in BioVersys’ IPO. The context BioVersys specialises in the identification, development and commercialization phases of novel antibacterial products for life-threatening infections caused by multi-drug resistant (MDR) bacteria. Beyond its home biotech lab of Basel, BioVersys is also operative in Lille (France), Delaware […]
Homburger advised Zürcher Kantonalbank (ZKB) as part of the joint lead management overseeing the successful issuance by Luzerner Kantonalbank (LUKB). ZKB acted as structuring advisor and joint-lead manager in connection with Luzerner Kantonalbank’s
Advestra advised Swiss chocolate manufacturer Barry Callebaut through successful CHF bond placement. The transaction The issuance, divided in two tranches, amounts to CHF 300 million in aggregate. The first tranche
Niederer Kraft Frey (NKF) advised Swiss company CGS, a full-service provider specialising in the disposal of landmines, Improvised Explosive Devices (IEDs) and other explosive hazards, on the sale of 2,532,055 shares in R&S Group (
Niederer Kraft Frey advised Société Générale and certain other financial institutions, all acting as joint lead managers in a 300 CHF bond issuance by Barry Callebaut, a Zurich-based global cocoa and chocolate product
Homburger advised BioVersys, a clinical-stage biopharmaceutical company domiciled in Basel, on all aspects of its Initial Public Offering (IPO). The Initial Public Offer The IPO was launched on SIX Swiss Exchange, comprising a primary
Homburger assisted AMAG Leasing, a Swiss car leasing services company, to successfully complete the issuance of CHF 100 m 1.625 per cent. Bonds. The fixed-income securities will eventually mature in 2028. AMAG Leasing’s is the subsidiary of
Walder Wyss advised Helvetia on the placement of two senior bond tranches totaling CHF 250 million. The first tranche is CHF 110 million, with a maturity in 2029 and a coupon of 0.80 percent. The second tranche is CHF 140
Walder Wyss advised Ronal, an alloy wheels for cars manufacturer, as borrower in connection with a Swiss law-governed EUR 155 million credit facilities agreement with UBS Switzerland as mandated lead arranger, original lender and agent and
Niederer Kraft Frey (NKF) advised Yttrium, a technology investor, on its Series B investment in Embotech, a provider of autonomous driving solutions, advised by Walder Wyss. Other investors in this funding round included Emerald Technology,
